Evaluation of peripheral enhancement on contrast-enhanced computed tomography and corresponding pathological findings in colorectal liver metastases after preoperative chemotherapy

被引:1
|
作者
Tamura, Akio [1 ]
Ishida, Kazuyuki [2 ]
Sone, Misato [1 ]
Yoshioka, Kunihiro [1 ]
机构
[1] Iwate Med Univ, Dept Radiol, Sch Med, 2-1-1 Idaidori, Shiwa, Iwate 0283695, Japan
[2] Dokkyo Med Univ, Dept Diagnost Pathol, 880 Kitakobayashi, Mibu, Tochigi, Japan
关键词
colorectal liver metastases; CT morphology; bevacizumab; radiopathological correlation; CANCER; BEVACIZUMAB;
D O I
10.5114/pjr.2023.127611
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To correlate peripheral enhancement on contrast-enhanced computed tomography (CE-CT) in patients with post-chemotherapy colorectal liver metastases (CRLM) with the corresponding pathological findings. Material and methods: Forty-four patients with CRLM who underwent hepatic resection after preoperative chemo-therapy between 2008 and 2013 were included. Two radiologists blinded to the histopathology findings performed a consensus categorization of the marginal contrast effects of CRLM on CE-CT as follows: Group 1, smooth margin without enhancement; Group 2, smooth margin with an enhanced rim; and Group 3, fuzzy margin with/without an enhanced rim. The Kruskal-Wallis test was used to compare the imaging findings with the histological findings. Results: The percentage of infarct-like necrosis was significantly higher in those with CRLM with smooth margins than in those with CRLM with fuzzy margins (p < 0.001, r = 0.62). The percentage of viable cells was lowest in CRLM with smooth margins without enhancement (p < 0.001, r = 0.60). Conclusions: Our findings suggest that the type of necrosis is related to the nature of the margins, and the presence of residual cells is related to peripheral enhancement.
引用
收藏
页码:e251 / e255
页数:5
相关论文
共 50 条
  • [41] Hepatectomy for Colorectal Cancer Liver Metastases in the Era of Modern Preoperative Chemotherapy: Evaluation of Postoperative Complications
    Kengo Fukuoka
    Satoshi Nara
    Yoshitaka Honma
    Yoji Kishi
    Minoru Esaki
    Kazuaki Shimada
    World Journal of Surgery, 2017, 41 : 1073 - 1081
  • [42] Contrast-enhanced intraoperative ultrasonography using perfluorobutane microbubbles for the enumeration of colorectal liver metastases
    Takahashi, M.
    Hasegawa, K.
    Arita, J.
    Hata, S.
    Aoki, T.
    Sakamoto, Y.
    Sugawara, Y.
    Kokudo, N.
    BRITISH JOURNAL OF SURGERY, 2012, 99 (09) : 1271 - 1277
  • [43] Colorectal liver metastases: Correlations of contrast-enhanced ultrasound features with tumor clinicopathological factors and clinical outcomes following conversion therapy
    Zhang, Xiao-Long
    Wang, Hang-Tao
    Tang, Yang
    Lu, Qing
    Yuan, Hai-Xia
    Wang, Xi
    Liu, Li-Heng
    Zhu, De-Xiang
    Wang, Wen-Ping
    CLINICAL HEMORHEOLOGY AND MICROCIRCULATION, 2024, 86 (03) : 339 - 356
  • [44] Extended Preoperative Chemotherapy Does Not Improve Pathologic Response and Increases Postoperative Liver Insufficiency After Hepatic Resection for Colorectal Liver Metastases
    Kishi, Yoji
    Zorzi, Dania
    Contreras, Carlo M.
    Maru, Dipen M.
    Kopetz, Scott
    Ribero, Dario
    Motta, Manuela
    Ravarino, Nicoletta
    Risio, Mauro
    Curley, Steven A.
    Abdalla, Eddie K.
    Capussotti, Lorenzo
    Vauthey, Jean-Nicolas
    ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (11) : 2870 - 2876
  • [45] Value of Contrast-Enhanced Ultrasound Quantification Criteria for Identifying Patients not Responding to Bevacizumab-Based Therapy for Colorectal Liver Metastases
    Tranquart, Francois
    Dujardin, Paul-Armand
    Bouche, Olivier
    Marcus, Claude
    Borg, Christophe
    Manzoni, Philippe
    Douillard, Jean-Yves
    Labbe-Devilliers, Catherine
    Terrebonne, Eric
    Smith, Denis
    Trillaud, Herve
    Capitain, Olivier
    Aube, Cristophe
    Spano, Jean-Philippe
    Lucidarme, Olivier
    Ferrul, Aurelie
    Tasu, Jean-Pierre
    Manfredi, Sylvain
    Bleuzen, Aurore
    Leger, Julie
    Lecomte, Thierry
    ULTRASCHALL IN DER MEDIZIN, 2018, 39 (05): : 544 - 558
  • [46] Treatment response assessment to chemotherapy with bevacizumab for colorectal liver metastasis by contrast-enhanced ultrasound
    Wu, Wen-Qing
    Wang, Xi
    Dong, Cai-Hong
    Mao, Li Juan
    Wan, Han-Tao
    Lu, Qing
    QUANTITATIVE IMAGING IN MEDICINE AND SURGERY, 2024, 14 (01) : 548 - 565
  • [47] Contrast Enhanced Ultrasound with SonoVue and Sonazoid for the Diagnosis of Colorectal Liver Metastasis after Chemotherapy
    Sun, Liqi
    Yin, Shanshan
    Xing, Baocai
    Li, Zhongwu
    Fan, Zhihui
    Yan, Kun
    JOURNAL OF ULTRASOUND IN MEDICINE, 2023, 42 (02) : 355 - 362
  • [48] Enhancement parameters of contrast-enhanced computed tomography for pancreatic ductal adenocarcinoma: Correlation with pathologic grading
    Seo, Woorim
    Kim, Young Chul
    Min, Seon Jeong
    Lee, Sang Min
    WORLD JOURNAL OF GASTROENTEROLOGY, 2020, 26 (28) : 4151 - 4158
  • [49] Comparison of Preoperative Images with Gross and Histopathological Findings of Liver Thin Slices in Patients with Liver Metastases from Colorectal Cancer after Chemotherapy
    Kasuya, Kazuhiko
    Oshiro, Hisashi
    Saito, Kazuhiro
    Suzuki, Yoshiaki
    Kikuchi, Satoru
    Kyo, Bunso
    Matsudo, Takaaki
    Nagakawa, Yuichi
    Itoi, Takao
    Tsuchida, Akihiko
    HEPATO-GASTROENTEROLOGY, 2012, 59 (116) : 981 - 985
  • [50] Evaluation of histopathological heterogeneity of colorectal cancer liver metastasis sites after preoperative chemotherapy
    Matsuhashi, Nobuhisa
    Tomita, Hiroyuki
    Tanaka, Hidenori
    Iwata, Yoshinori
    Matsui, Satoshi
    Imai, Hisashi
    Fukada, Masahiro
    Mizutani, Chika
    Takahashi, Takao
    Yasufuku, Itaru
    Suetsugu, Tomonari
    Mori, Ryutaro
    Tanaka, Yoshihiro
    Okumura, Naoki
    Futamura, Manabu
    Yoshida, Kazuhiro
    MOLECULAR AND CLINICAL ONCOLOGY, 2022, 16 (03)